https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Aims The changing medicolegal climate regarding the medicinal use of cannabinoids in New Zealand will increase the likelihood of patients consulting general practitioners (GPs) about these products. Arthritis is a common medical condition for which cannabis-based products are promoted and used; however, doctors' knowledge about the efficacy and safety of these products in the setting of arthritis may be limited. Methods We undertook a rapid review of the medical literature on cannabis-based medicinal products in arthritis. Results Ani
Me gusta
Comentario
Compartir
